Large-scale testing (Phase 3)Study completedNCT02136914
What this trial is testing
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Who this might be right for
DyskinesiaLevodopa Induced Dyskinesia (LID)Parkinson's Disease
Adamas Pharmaceuticals, Inc. 126